Technical Specifications Total Mass : 20mg Components : BPC-157 and TB-500 Form : Co-lyophilized powder COA : Provided (batch-specific HPLC and MS data) Storage & Handling Store lyophilized at 20C for long-term stability
intravenous TB-4 Phase 1 safety and pharmacokinetics, no dose-limiting or serious adverse events (Ann N Y Acad Sci 2010;1194:223229): NCT00743769 Medical Disclaimer The content in this calculator is for informational purposes only and does not constitute medical advice
During this consultation, we will review your medical history, any current medications, allergies, past treatments, and pre-existing conditions, current weight, order possible lab work, and address any questions or concerns, as well as provide general guidance on lifestyle, exercise, and nutrition
Studies show its well-tolerated even at high doses with no significant adverse reactions
Healthy cells in both of these systems are supported by B12, specifically in the creation of new cells within these systems
Allows multiple withdrawals from one vial when stored properly
